Valaciclovir "Orion"

{
  "EntityId": "6539",
  "LastUpdated": "2026-07-17T00:37:06.055392\u002B02:00",
  "LastRevisedDate": {
    "Header": "Revisionsdato",
    "Value": "\u003Cdiv id=\u0022revisionsdato\u0022\u003E\u003Cp\u003E\u003Cspan class=\u0022dato\u0022\u003ETirsdag den 2. september 2025\u003C/span\u003E. Priserne er dog g\u00E6ldende pr.\u003Cspan class=\u0022dato\u0022\u003Emandag den 6. juli 2026.\u003C/span\u003E\u003Cdiv class=\u0022smalltext\u0022\u003EDer kan forekomme forskelle mellem pr\u00E6paratbeskrivelsen og oplysningerne i produktresumeet og/eller indl\u00E6gssedlen. Det skyldes, at min.medicin.dk kan have suppleret L\u00E6gemiddelstyrelsens og producentens pr\u00E6paratinformationer med andre kilder. Min.medicin.dk har det fulde ansvar for pr\u00E6paratbeskrivelserne.\u003C/div\u003E\u003C/p\u003E\u003C/div\u003E"
  },
  "MedicineName": {
    "Header": "Pr\u00E6paratnavn",
    "Value": "Valaciclovir \u0022Orion\u0022"
  },
  "TradeNames": {
    "Header": "Handelsnavne",
    "Value": []
  },
  "Slug": "valaciclovir-orion",
  "CompanyName": {
    "Header": "Firmanavn",
    "Value": "Orion Pharma"
  },
  "Usage": {
    "Header": "Bruges mod",
    "Value": "\u003Cdiv id=\u0022anvendelse\u0022\u003E\u003Cp\u003EValaciclovir \u0022Orion\u0022 er et middel mod herpesinfektioner.\u003C/p\u003E\u003Cp\u003EValaciclovir \u0022Orion\u0022 anvendes til\u003C/p\u003E\u003Cul\u003E\u003Cli\u003EBehandling af infektioner med herpesvirus, is\u00E6r helvedesild\u003C/li\u003E\u003Cli\u003EForebyggelse og behandling af: \u003Cul\u003E\u003Cli\u003Etilbagevendende herpes p\u00E5 k\u00F8nsdelene\u003C/li\u003E\u003Cli\u003Einfektion med herpesvirus i hud og slimhinder \u003C/li\u003E\u003Cli\u003Einfektion med herpesvirus i \u00F8jne \u003C/li\u003E\u003C/ul\u003E\u003C/li\u003E\u003Cli\u003EForebyggelse mod infektion med cytomegalovirus efter organtransplantation. \u003C/li\u003E\u003C/ul\u003E\u003C/div\u003E"
  },
  "Dosage": {
    "Header": "Dosering",
    "Value": "\u003Cdiv id=\u0022doseringsforslag\u0022\u003E\u003Cp\u003EFindes som tabletter.\u003C/p\u003E\u003Cp\u003E\u003Cb\u003EHelvedesild\u003C/b\u003E\u003C/p\u003E\u003Cul\u003E\u003Cli\u003E\u003Cb\u003EVoksne. \u003C/b\u003ES\u00E6dvanligvis 1.000 mg 3 gange i d\u00F8gnet i 7 dage. \u003C/li\u003E\u003C/ul\u003E\u003Cp\u003E\u003Cb\u003EHerpes p\u00E5 hud og slimhinder, fx p\u00E5 k\u00F8nsdelene\u003C/b\u003E\u003C/p\u003E\u003Cul\u003E\u003Cli\u003E\u003Cb\u003EVoksne og b\u00F8rn over 12 \u00E5r\u003C/b\u003E\u003Cul\u003E\u003Cli\u003ES\u00E6dvanligvis 1.000 mg 2 gange i d\u00F8gnet i 5 dage\u003Cbr/\u003E\u003Cb\u003Eeller\u003C/b\u003E\u003C/li\u003E\u003Cli\u003E500 mg 2 gange i d\u00F8gnet i 5 dage. \u003C/li\u003E\u003C/ul\u003E\u003C/li\u003E\u003C/ul\u003E\u003Cp\u003E\u003Cb\u003ETilbagevendende fork\u00F8lelsess\u00E5r\u003C/b\u003E\u003C/p\u003E\u003Cul\u003E\u003Cli\u003E\u003Cb\u003EVoksne og b\u00F8rn over 12 \u00E5r\u003C/b\u003E\u003Cul\u003E\u003Cli\u003E2.000 mg 2 gange i d\u00F8gnet i 1 d\u00F8gn. \u003C/li\u003E\u003C/ul\u003E\u003C/li\u003E\u003C/ul\u003E\u003Cp\u003E\u003Cb\u003EForebyggelse mod herpes p\u00E5 hud og slimhinder, fx p\u00E5 k\u00F8nsdelene\u003C/b\u003E\u003C/p\u003E\u003Cul\u003E\u003Cli\u003E\u003Cb\u003EVoksne og b\u00F8rn over 12 \u00E5r\u003C/b\u003E\u003Cul\u003E\u003Cli\u003ES\u00E6dvanligvis 500 mg 2 gange i d\u00F8gnet\u003Cbr/\u003E\u003Cb\u003Eeller\u003C/b\u003E\u003C/li\u003E\u003Cli\u003E250 mg 2 gange i d\u00F8gnet. \u003C/li\u003E\u003C/ul\u003E\u003C/li\u003E\u003C/ul\u003E\u003Cp\u003E\u003Cb\u003EForebyggelse mod infektion med cytomegalovirus efter organtransplantation\u003C/b\u003E\u003C/p\u003E\u003Cul\u003E\u003Cli\u003E\u003Cb\u003EVoksne og b\u00F8rn over 12 \u00E5r\u003C/b\u003E\u003Cul\u003E\u003Cli\u003E2.000 mg 4 gange i d\u00F8gnet.\u003C/li\u003E\u003C/ul\u003E\u003C/li\u003E\u003C/ul\u003E\u003Cp\u003E\u003Cb\u003EBem\u00E6rk:\u003C/b\u003E\u003C/p\u003E\u003Cul\u003E\u003Cli\u003EBehandlingen skal indledes hurtigst muligt og senest 3 d\u00F8gn efter udbrud. \u003C/li\u003E\u003Cli\u003EDet er vigtigt med tilstr\u00E6kkelig v\u00E6skeindtagelse under behandlingen. \u003C/li\u003E\u003Cli\u003EDosis skal neds\u00E6ttes ved d\u00E5rligt fungerende nyrer (GFR 10-75 ml/min)\u003C/li\u003E\u003C/ul\u003E\u003Cbr/\u003E\u003C/div\u003E"
  },
  "HowToUse": {
    "Header": "S\u00E5dan tager du medicinen",
    "Value": {
      "KnuseDeleInformation": {
        "Header": "H\u00E5ndtering",
        "Value": "\u003Cdiv id=\u0022KnuseDeleInformation\u0022\u003E\u003Cp\u003E\u003Cdiv\u003E\u003Ch4\u003E\u003Cspan data-drugid=\u002228104408308\u0022\u003E\u003Cb\u003EFilmovertrukne tabletter 500 mg\u003C/b\u003E\u003C/span\u003E\u003Cbr/\u003E\u003C/h4\u003E\u003Cbr/\u003E\u003Cb\u003EMad og drikke\u003C/b\u003E\u003Cdiv\u003ETages med et glas vand\u003Cbr/\u003EKan tages med eller uden mad\u003Cbr/\u003EKnust tablet kan kommes p\u00E5 kold, bl\u00F8d mad\u003C/div\u003E\u003Cbr/\u003E\u003Cb\u003EKnusning/\u00E5bning\u003C/b\u003E\u003Cdiv\u003EKan knuses\u003C/div\u003E\u003Cbr/\u003E\u003Cb\u003EAdministration\u003C/b\u003E\u003Cdiv\u003EKan synkes hele eller halve\u003Cbr/\u003EKnust tablet kan opsl\u00E6mmes i vand\u003C/div\u003E\u003C/div\u003E\u003C/p\u003E\u003C/div\u003E"
      },
      "Termination": {
        "Header": "Stop af behandling",
        "Value": null
      },
      "MissedDose": {
        "Header": "Glemt medicin",
        "Value": null
      }
    }
  },
  "Precautions": {
    "Header": "Det skal du vide, n\u00E5r du tager medicinen",
    "Value": {
      "Contraindications": {
        "Header": "Hvorn\u00E5r m\u00E5 du ikke tage medicinen?",
        "Value": "\u003Cdiv id=\u0022boerikkeanvendes\u0022\u003E\u003Cp\u003EMidlet m\u00E5 ikke anvendes ved allergi over for aciclovir, famciclovir, ganciclovir, penciclovir eller valganciclovir.\u003C/p\u003E\u003C/div\u003E"
      },
      "RulesOfCaution": {
        "Header": "S\u00E6rlige advarsler",
        "Value": "\u003Cdiv id=\u0022saerligeadvarsler\u0022\u003E\u003Cp\u003EDu skal straks kontakte din l\u00E6ge, hvis du under behandlingen f\u00E5r tegn p\u00E5 alvorlige overf\u00F8lsomhedsreaktioner eller hudreaktioner. Behandlingen vil straks skulle oph\u00F8re, da der er rapporteret om alvorlige og livstruende hudreaktioner.\u003C/p\u003E\u003C/div\u003E"
      },
      "Interactions": {
        "Header": "Brug af anden medicin",
        "Value": "\u003Cdiv id=\u0022brugafandenmedicin\u0022\u003E\u003Cp\u003EDet er vigtigt at informere l\u00E6gen om alle de l\u00E6gemidler, du tager.\u003C/p\u003E\u003Cul\u003E\u003Cli\u003EProbenecid (middel mod urinsyregigt) \u00F8ger virkningen af Valaciclovir \u0022Orion\u0022. \u003C/li\u003E\u003C/ul\u003E\u003C/div\u003E"
      },
      "Pregnancy": {
        "Header": "Graviditet og fertilitet",
        "Value": "\u003Cdiv id=\u0022graviditet\u0022\u003EKan om n\u00F8dvendigt anvendes.\u003C/div\u003E"
      },
      "Lactation": {
        "Header": "Amning",
        "Value": "\u003Cdiv id=\u0022amning\u0022\u003EKan om n\u00F8dvendigt anvendes.\u003C/div\u003E"
      },
      "Alchohol": {
        "Header": "Alkohol",
        "Value": "\u003Cdiv id=\u0022alkohol\u0022\u003E\u003Cp\u003E\u003Cp\u003EAlkohol og Valaciclovir \u0022Orion\u0022 p\u00E5virker ikke hinanden.\u003C/p\u003E\u003Cp\u003EF\u00F8lg dog altid Sundhedsstyrelsens anbefalinger om genstandsgr\u00E6nser.\u003C/p\u003E\u003C/p\u003E\u003C/div\u003E"
      },
      "BloodDonor": {
        "Header": "Bloddonor",
        "Value": "\u003Cdiv id=\u0022bloddonor\u0022\u003EM\u00E5 ikke tappes. 1 d\u00F8gns karant\u00E6ne.\u003Cbr/\u003EIngen karant\u00E6ne ved tapning af plasma til fraktionering.\u003C/div\u003E"
      },
      "Doping": {
        "Header": "Doping",
        "Value": null
      },
      "Traffic": {
        "Header": "Trafik",
        "Value": null
      },
      "SchengenCertificate": {
        "Header": "Schengenattest (pillepas)",
        "Value": null
      },
      "ShelfLifeAndStorage": {
        "Header": "Holdbarhed og opbevaring",
        "Value": null
      }
    }
  },
  "SideEffects": {
    "Header": "Bivirkninger",
    "Value": {
      "VeryCommon": {
        "Header": "Meget almindelige",
        "Comment": "Flere end 10 ud af 100 personer f\u00E5r bivirkningen.",
        "Value": {
          "SeriousAdverseReactions": {
            "Header": "Potentielt alvorlige bivirkninger",
            "Value": []
          },
          "NonSeriousAdverseReactions": {
            "Header": "Oftest ikke alvorlige bivirkninger",
            "Value": [
              "Hovedpine"
            ]
          }
        }
      },
      "Common": {
        "Header": "Almindelige",
        "Comment": "H\u00F8jst 10 ud af 100 personer f\u00E5r bivirkningen.",
        "Value": {
          "SeriousAdverseReactions": {
            "Header": "Potentielt alvorlige bivirkninger",
            "Value": [
              "Svimmelhed"
            ]
          },
          "NonSeriousAdverseReactions": {
            "Header": "Oftest ikke alvorlige bivirkninger",
            "Value": [
              "Diarr\u00E9",
              "Kvalme",
              "Opkastning"
            ]
          }
        }
      },
      "Uncommon": {
        "Header": "Ikke almindelige",
        "Comment": "H\u00F8jst 1 ud af 100 personer f\u00E5r bivirkningen.",
        "Value": {
          "SeriousAdverseReactions": {
            "Header": "Potentielt alvorlige bivirkninger",
            "Value": [
              "\u00D8get risiko for infektioner pga. mangel p\u00E5 hvide blodlegemer",
              "\u00D8get tendens til bl\u00F8dning pga. fald i antallet af blodplader",
              "Forh\u00F8jet galdefarvestof",
              "Leverp\u00E5virkning",
              "Bevidsthedssv\u00E6kkelse",
              "Forvirring",
              "Hallucinationer",
              "P\u00E5virkning af nyrerne",
              "Overf\u00F8lsomhed over for sollys"
            ]
          },
          "NonSeriousAdverseReactions": {
            "Header": "Oftest ikke alvorlige bivirkninger",
            "Value": [
              "Hudkl\u00F8e",
              "Hududsl\u00E6t"
            ]
          }
        }
      },
      "Rare": {
        "Header": "Sj\u00E6ldne",
        "Comment": "H\u00F8jst 1 ud af 1.000 personer f\u00E5r bivirkningen.",
        "Value": {
          "SeriousAdverseReactions": {
            "Header": "Potentielt alvorlige bivirkninger",
            "Value": [
              "Allergisk h\u00E6velse i ansigtet samt mundhulen og strubehovedet",
              "Anafylaktisk chok - en akut alvorlig allergisk tilstand",
              "Kramper",
              "Besv\u00E6r med at styre arme og ben",
              "Koma",
              "P\u00E5virkning af hjernen",
              "Delirium - en tilstand med konfusion og p\u00E5virkning af syns- og h\u00F8reindtryk",
              "Psykoser"
            ]
          },
          "NonSeriousAdverseReactions": {
            "Header": "Oftest ikke alvorlige bivirkninger",
            "Value": [
              "N\u00E6ldefeber"
            ]
          }
        }
      },
      "VeryRare": {
        "Header": "Meget sj\u00E6ldne",
        "Comment": "H\u00F8jst 1 ud af 10.000 personer f\u00E5r bivirkningen.",
        "Value": {
          "SeriousAdverseReactions": {
            "Header": "Potentielt alvorlige bivirkninger",
            "Value": [
              "Kronisk nyresygdom"
            ]
          },
          "NonSeriousAdverseReactions": {
            "Header": "Oftest ikke alvorlige bivirkninger",
            "Value": []
          }
        }
      },
      "FrequencyNotKnown": {
        "Header": "Ikke kendt",
        "Comment": null,
        "Value": {
          "SeriousAdverseReactions": {
            "Header": "Potentielt alvorlige bivirkninger",
            "Value": [
              "Nyrebet\u00E6ndelse",
              "Alvorlig l\u00E6gemiddelreaktion med p\u00E5virkning af de indre organer"
            ]
          },
          "NonSeriousAdverseReactions": {
            "Header": "Oftest ikke alvorlige bivirkninger",
            "Value": []
          }
        }
      }
    },
    "AdditionalSideEffectsText": "\u003Ch4\u003EPraktiske erfaringer\u003C/h4\u003E\u003Cul\u003E\u003Cli\u003EDe mest almindelige bivirkninger er hovedpine og kvalme. \u003C/li\u003E\u003C/ul\u003E"
  },
  "ActiveSubstances": {
    "Header": "Virksomme stoffer",
    "Value": [
      {
        "Name": "Valaciclovir"
      }
    ]
  },
  "Products": {
    "Header": "Priser, pakninger og tilskud",
    "Value": [
      {
        "ProductNumber": "529448",
        "DisplayName": "Valaciclovir \u0022Orion\u0022 500 mg / 10 stk. (blister)",
        "Packaging": "10 stk. (blister)",
        "Price": 76.2,
        "PricePerUnit": 7.62,
        "TradeName": "Valaciclovir \u0022Orion\u0022",
        "PharmaceuticalForm": "Filmovertrukne tabletter",
        "DrugStrength": "500 mg",
        "Dispensing": "Receptpligtigt, flere udleveringer",
        "Reimbursement": "Generelt medicintilskud",
        "ExpirationDate": null,
        "IsVariablePrice": false,
        "Substitutes": [
          {
            "ProductNumber": "152653",
            "Slug": "valaciclovir-bluefish",
            "DisplayName": "Valaciclovir \u0022Bluefish\u0022 500 mg / 10 stk. (blister)",
            "Price": 71.5,
            "PricePerUnit": 7.15,
            "SubstitutionPriceGroup": "A",
            "ExpirationDate": null,
            "IsVariablePrice": false
          },
          {
            "ProductNumber": "035999",
            "Slug": "valaciclovir-viatris",
            "DisplayName": "Valaciclovir \u0022Viatris\u0022 500 mg / 10 stk. (blister)",
            "Price": 76.5,
            "PricePerUnit": 7.65,
            "SubstitutionPriceGroup": "C",
            "ExpirationDate": null,
            "IsVariablePrice": false
          },
          {
            "ProductNumber": "427501",
            "Slug": "valaciclovir-sandoz",
            "DisplayName": "Valaciclovir \u0022Sandoz\u0022 500 mg / 10 stk. (blister)",
            "Price": 79.5,
            "PricePerUnit": 7.95,
            "SubstitutionPriceGroup": "C",
            "ExpirationDate": null,
            "IsVariablePrice": false
          },
          {
            "ProductNumber": "041443",
            "Slug": "valaciclovir-teva",
            "DisplayName": "Valaciclovir \u0022Teva\u0022 500 mg / 10 stk. (blister)",
            "Price": 79.75,
            "PricePerUnit": 7.97,
            "SubstitutionPriceGroup": "C",
            "ExpirationDate": null,
            "IsVariablePrice": false
          }
        ]
      },
      {
        "ProductNumber": "129472",
        "DisplayName": "Valaciclovir \u0022Orion\u0022 500 mg / 30 stk. (blister)",
        "Packaging": "30 stk. (blister)",
        "Price": null,
        "PricePerUnit": null,
        "TradeName": "Valaciclovir \u0022Orion\u0022",
        "PharmaceuticalForm": "Filmovertrukne tabletter",
        "DrugStrength": "500 mg",
        "Dispensing": "Receptpligtigt, flere udleveringer",
        "Reimbursement": "Generelt medicintilskud",
        "ExpirationDate": "20260608",
        "IsVariablePrice": false,
        "Substitutes": []
      },
      {
        "ProductNumber": "183101",
        "DisplayName": "Valaciclovir \u0022Orion\u0022 500 mg / 42 stk. (blister)",
        "Packaging": "42 stk. (blister)",
        "Price": 190.15,
        "PricePerUnit": 4.53,
        "TradeName": "Valaciclovir \u0022Orion\u0022",
        "PharmaceuticalForm": "Filmovertrukne tabletter",
        "DrugStrength": "500 mg",
        "Dispensing": "Receptpligtigt, flere udleveringer",
        "Reimbursement": "Generelt medicintilskud",
        "ExpirationDate": null,
        "IsVariablePrice": false,
        "Substitutes": [
          {
            "ProductNumber": "119674",
            "Slug": "valaciclovir-sandoz",
            "DisplayName": "Valaciclovir \u0022Sandoz\u0022 500 mg / 42 stk. (blister)",
            "Price": 146.15,
            "PricePerUnit": 3.48,
            "SubstitutionPriceGroup": "A",
            "ExpirationDate": null,
            "IsVariablePrice": false
          },
          {
            "ProductNumber": "433635",
            "Slug": "valaciclovir-viatris",
            "DisplayName": "Valaciclovir \u0022Viatris\u0022 500 mg / 42 stk. (blister)",
            "Price": 163.1,
            "PricePerUnit": 3.88,
            "SubstitutionPriceGroup": "C",
            "ExpirationDate": null,
            "IsVariablePrice": false
          },
          {
            "ProductNumber": "152675",
            "Slug": "valaciclovir-bluefish",
            "DisplayName": "Valaciclovir \u0022Bluefish\u0022 500 mg / 42 stk. (blister)",
            "Price": 176.3,
            "PricePerUnit": 4.2,
            "SubstitutionPriceGroup": "C",
            "ExpirationDate": null,
            "IsVariablePrice": false
          },
          {
            "ProductNumber": "041465",
            "Slug": "valaciclovir-teva",
            "DisplayName": "Valaciclovir \u0022Teva\u0022 500 mg / 42 stk. (blister)",
            "Price": 216.05,
            "PricePerUnit": 5.14,
            "SubstitutionPriceGroup": "C",
            "ExpirationDate": null,
            "IsVariablePrice": false
          }
        ]
      }
    ]
  },
  "Excipients": {
    "Header": "Hj\u00E6lpestoffer",
    "Value": [
      "\u003Cdiv id=\u0022hjaelpestoffer\u0022\u003E\u003Cp\u003E\u003Cb\u003EFarve:\u003C/b\u003E\u003C/p\u003E\u003Cspan class=\u0022navn\u0022\u003EIndigotin\u00A0(indigocarmin) (E132)\u003C/span\u003E : \u003Cspan class=\u0022dispenseringsformogstyrke\u0022\u003Efilmovertrukne tabletter 500 mg\u003C/span\u003E\u003Cbr/\u003E\u003Cspan class=\u0022navn\u0022\u003ETitandioxid (E171)\u003C/span\u003E : \u003Cspan class=\u0022dispenseringsformogstyrke\u0022\u003Efilmovertrukne tabletter 500 mg\u003C/span\u003E\u003Cp\u003E\u003Cb\u003EAndre:\u003C/b\u003E\u003C/p\u003E\u003Cspan class=\u0022navn\u0022\u003ECrospovidon\u003C/span\u003E : \u003Cspan class=\u0022dispenseringsformogstyrke\u0022\u003Efilmovertrukne tabletter 500 mg\u003C/span\u003E\u003Cbr/\u003E\u003Cspan class=\u0022navn\u0022\u003EHypromellose\u003C/span\u003E : \u003Cspan class=\u0022dispenseringsformogstyrke\u0022\u003Efilmovertrukne tabletter 500 mg\u003C/span\u003E\u003Cbr/\u003E\u003Cspan class=\u0022navn\u0022\u003EMacrogoler\u003C/span\u003E : \u003Cspan class=\u0022dispenseringsformogstyrke\u0022\u003Efilmovertrukne tabletter 500 mg\u003C/span\u003E\u003Cbr/\u003E\u003Cspan class=\u0022navn\u0022\u003EMagnesiumstearat\u003C/span\u003E : \u003Cspan class=\u0022dispenseringsformogstyrke\u0022\u003Efilmovertrukne tabletter 500 mg\u003C/span\u003E\u003Cbr/\u003E\u003Cspan class=\u0022navn\u0022\u003EMikrokrystallinsk cellulose\u003C/span\u003E : \u003Cspan class=\u0022dispenseringsformogstyrke\u0022\u003Efilmovertrukne tabletter 500 mg\u003C/span\u003E\u003Cbr/\u003E\u003Cspan class=\u0022navn\u0022\u003EPolysorbat\u003C/span\u003E : \u003Cspan class=\u0022dispenseringsformogstyrke\u0022\u003Efilmovertrukne tabletter 500 mg\u003C/span\u003E\u003Cbr/\u003E\u003Cspan class=\u0022navn\u0022\u003EPovidon K90\u003C/span\u003E : \u003Cspan class=\u0022dispenseringsformogstyrke\u0022\u003Efilmovertrukne tabletter 500 mg\u003C/span\u003E\u003C/div\u003E"
    ]
  },
  "PharmacologicalEffect": {
    "Header": "S\u00E5dan virker medicinen",
    "Value": "\u003Cdiv id=\u0022virkning\u0022\u003E\u003Cul\u003E\u003Cli\u003EVirker ved at h\u00E6mme dannelsen af herpesvirus i herpessmittede celler. \u003C/li\u003E\u003Cli\u003EHalveringstid i blodet (T\u00BD) er ca. 3 timer. \u003C/li\u003E\u003C/ul\u003E\u003C/div\u003E"
  },
  "Reimbursement": {
    "Header": "Tilskud",
    "Value": null
  }
}